Table 2.
Included N=346 |
Excluded N=189 |
p-value† | |
---|---|---|---|
Mean Age (SD), years | 57.1 (13.9) | 58.4 (14.9) | 0.39 |
Female (%) | 43.9% | 50.2% | 0.15 |
Wegener’s Granulomatosis (%) | 58.5% | 41.6% | <0.001 |
Mean Baseline BVAS (SD) | 17.6 (8.5) | 19.2 (8.4) | 0.041 |
Median eGFR (IQR), ml/min | 33.5 (10.9 to 70.0) | 18.9 (7.6 to 51.9) | <0.001‡ |
Organ Involvement (%) | |||
General | 91.9 | 87.1 | 0.009 |
Cutaneous | 23.5 | 23.9 | 0.91 |
Mucous Membrane/Eye | 30.4 | 26.4 | 0.22 |
ENT | 52.9 | 46.0 | 0.036 |
Chest | 52.5 | 46.6 | 0.071 |
Cardiac | 5.7 | 4.9 | 0.69 |
Abdominal | 4.7 | 6.7 | 0.18 |
Renal | 86.8 | 92.3 | 0.007 |
Neurologic | 20.1 | 20.8 | 0.81 |
p-values from t-tests for continuous variables or Fisher’s exact test for categorical variables except where noted;
p-value from Mann-Whitney test.
SD = standard deviation; BVAS = Birmingham Vasculitis Activity Score; eGFR = estimated glomerular filtration rate; IQR = interquartile range; ENT = ears, nose and throat.